The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning
Open Access
- 1 June 2011
- journal article
- Published by Taylor & Francis Ltd in Clinical Toxicology
- Vol. 49 (5), 366-373
- https://doi.org/10.3109/15563650.2011.584879
Abstract
Context. Cyanide is a component of smoke in residential and industrial fires, and accidental exposure to cyanide occurs in a variety of industries. Moreover, cyanide has the potential to be used by terrorists, particularly in a closed space such as an airport or train station. Current therapies for cyanide poisoning must be given by intravenous administration, limiting their use in treating mass casualties. Objective. We are developing two new cyanide antidotes – cobinamide, a vitamin B12 analog, and sulfanegen, a 3-mercaptopyruvate prodrug. Both drugs can be given by intramuscular administration, and therefore could be used to treat a large number of people quickly. We now asked if the two drugs would have an augmented effect when combined. Materials and methods. We used a non-lethal and two different lethal models of cyanide poisoning in mice. The non-lethal model assesses neurologic recovery by quantitatively evaluating the innate righting reflex time of a mouse. The two lethal models are a cyanide injection and a cyanide inhalation model. Results. We found that the two drugs are at least additive when used together in both the non-lethal and lethal models: at doses where all animals died with either drug alone, the combination yielded 80 and 40% survival in the injection and inhalation models, respectively. Similarly, drug doses that yielded 40% survival with either drug alone, yielded 80 and 100% survival in the injection and inhalation models, respectively. As part of the inhalation model, we developed a new paradigm in which animals are exposed to cyanide gas, injected intramuscularly with an antidote, and then re-exposed to cyanide gas. This simulates cyanide exposure of a large number of people in a closed space, because people would remain exposed to cyanide, even after receiving an antidote. Conclusion. The combination of cobinamide and sulfanegen shows great promise as a new approach to treating cyanide poisoning.Keywords
This publication has 32 references indexed in Scilit:
- Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicityToxicology and Applied Pharmacology, 2010
- Cobinamide is superior to other treatments in a mouse model of cyanide poisoningClinical Toxicology, 2010
- Hydroxocobalamin and Sodium Thiosulfate Versus Sodium Nitrite and Sodium Thiosulfate in the Treatment of Acute Cyanide Toxicity in a Swine (Sus scrofa) ModelAnnals of Emergency Medicine, 2010
- Intramuscular Cobinamide Sulfite in a Rabbit Model of Sublethal Cyanide ToxicityAnnals of Emergency Medicine, 2010
- A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in miceToxicology Letters, 2007
- Novel, Orally Effective Cyanide AntidotesJournal of Medicinal Chemistry, 2007
- Prospective Study of Hydroxocobalamin for Acute Cyanide Poisoning in Smoke InhalationAnnals of Emergency Medicine, 2007
- Reactions of Nitric Oxide with Vitamin B12and Its Precursor, CobinamideBiochemistry, 2003
- Cyanide Antidotes and Methods of Their Administration in Dogs:Anesthesiology, 1980
- Prevention of Nitroprusside-Induced Cyanide Toxicity with HydroxocobalaminThe New England Journal of Medicine, 1978